• 1
    Holland GN. AIDS and ophthalmology: The first quarter century. Am J Ophthalmol 2008; 146: 397408
  • 2
    Jabs DA, Van Natta ML, Kempen JH, Reed Pavan P, Lim JI, Murphy RL, Hubbard LD. Characteristics of patients with cytomegalovirus retinitis in the era of highly active antiretroviral therapy. Am J Ophthalmol 2002; 133: 4861.
  • 3
    Jacobson MA, Stanley H, Holtzer C, Margolis TP, Cunningham ET. Natural history and outcomes of new AIDS-related cytomegalovirus retinitis diagnosed in the era of highly active antiretroviral therapy. Clin Infect Dis 2000; 30: 231233.
  • 4
    Plummer DJ, Sample PA, Arevalo JF, Grant I, Quiceno JI, Dua R, Freeman WR. Visual field loss in HIV-positive patients without infectious retinopathy. Am J Ophthalmol 1996; 122: 542549.
  • 5
    Quinceno JI, Capparelli E, Sadunn AA, Munguia D, Grant I, Listhaus A, Capotta J et al. Visual dysfunction without retinopathy in patients with acquired immunodeficiency syndrome. Am J Ophthalmol 1992; 113: 813.
  • 6
    Mueller AJ, Plummer DJ, Dua R, Taskintuna I, Sample PA, Grant I, Freeman WR. Analysis of visual dysfunctions in HIV-positive patients without retinitis. Am J Ophthalmol 1997; 124: 158167.
  • 7
    Latkany PA, Holopigian K, Lorenzo-Latkany M, Seiple M. Electroretinographic and psychophysical findings during early and late stages of human immunodeficiency virus infection and cytomegalovirus retinitis. Ophthalmology 1997; 104: 445453.
  • 8
    Freeman WR, Chen A, Henderly DE, Levine AM, Luttrull JK, Urrea PT, Arthur J et al. Prevalence and significance of acquired immunodeficiency syndrome-related retinal microvasculopathy. Am J Ophthalmol 1989; 15: 229235.
  • 9
    Falkenstein I, Kozak I, Kayikcioglu O, Cheng L, Bartsch DU, Azen SP, Lauree LD et al. Assessment of retinal function in patients without infectious retinitis by multifocal electroretinogram and automated perimetry. Retina 2006; 26: 928934.
  • 10
    Hood DC, Bach M, Brigell M, Keating D, Kondo M, Lyons JS, Palmowski-Wolfe AM. ISCEV guidelines for clinical multifocal-electroretinography. Doc Ophthalmol 2007; 116: 111.
  • 11
    Jaffe GH, Caprioli J. Optical coherence tomography to detect and mange retinal disease and glaucoma. Am J Ophthalmol 2004; 137: 156169.
  • 12
    Huang D, Swanson EA, Lin CP, Schuman JS, Stinson WG, Chang W, Hee MR et al. Optical coherence tomography. Science 1991; 254: 11781181.
  • 13
    Hee MR, Izatt JA, Swanson EA, Huang D, Schuman JS, Lin CP, Puliafito CA et al. Optical coherence tomography of the human retina. Arch Ophthalmol 1995; 124: 325332.
  • 14
    Moschos MM, Mostrou G, Psimenidou E, Spoulou V, Theodoridou M. Objective analysis of retinal function in HIV-positive children without retinitis using optical coherence tomography. Ocul Immunol Inflamm 2007; 15: 319323.
  • 15
    Sutter EE, Tran D. The field topography of ERG components in man. 1. The photopic luminance response. Vision Res 1992; 32: 433466.
  • 16
    Kondo M, Miyake Y, Horiguchi M, Suzuki S, Tanikawa A. Clinical evaluation of multifocal electroretinogram. Invest Ophthalmol Vis Sci 1995; 36: 21462150.
  • 17
    Guex-Crosier Y. The pathogenesis and clinical presentation of macular edema in inflammatory diseases. Doc Ophthalmol 1999; 97: 297309.
  • 18
    Choi JY, Buzney SM, Weiter JJ. Cystoid macular edema: current modes of therapy. Int Ophthalmol Clin 2005; 45: 143151.
  • 19
    Miyake Y, Horiguchi M, Tomita N, Kondo M, Tanikawa A, Takahashi H, Suzuki S et al. Occult macular dystrophy. Am J Ophthalmol 1996; 122: 644653.
  • 20
    Falkenstein IA, Bartsch DU, Azen SP, Dustin L, Sadun AA, Freeman WR. Multifocal electroretinography in HIV-positive patients without infectious retinitis. Am J Ophthalmol 2008; 146: 579588.